Federal Agencies Fund Ibogaine Research for PTSDFederal Research Could Open a Path to Ibogaine TreatmentIbogaine Research Must Put Safety Ahead of a Fast Approval Push
On November 12, the Trump administration announced federal funding to prepare and accelerate research into ibogaine as a potential option for PTSD, substance dependence and other mental health conditions.On November 12, the Trump administration announced federal funding to advance research into ibogaine for PTSD, addiction and other mental health conditions, including conditions affecting veterans.The Trump administration announced on November 12 that federal agencies would fund groundwork to study ibogaine for PTSD and other conditions, despite the drug’s serious heart risks.